Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Table of Contents
outlinetrue

Introduction

Ontologies are a representation of domain knowledge using defined concepts and the relationships between those concepts in a manner understandable to both humans and machines.

...

The role concept (hereafter referred to as 'role') and corresponding ontological role model pattern provide a structured and modular way to capture many different real-world complexities.


Universal Statement (NO Role usage)

Drawio
bordertrue
diagramNameGeneral Pattern for Contextualized Roles
simpleViewerfalse
width
linksauto
tbstyletop
diagramDisplayNameGeneral pattern for contextualized roles
lboxtrue
diagramWidth591
revision22

Example: Amlodipine Mesylate Monohydrate is included Amlodipine EMC (a pharmaceutical product)

Drawio
bordertrue
diagramNameSubstance included in product - Amlodipine mesylate monohydrate included in Amlodipine EMC
simpleViewerfalse
width
linksauto
tbstyletop
lboxtrue
diagramWidth761
revision1

Basic Role Pattern

In order to further specify a relationship we use the basic role pattern that allows to provide details that are valid only in a certain context.

Drawio
bordertrue
diagramNameContextualized Role
simpleViewerfalse
width
linksauto
tbstyletop
lboxtrue
diagramWidth591
revision2

Example: Amlodpine Besylate plays role active ingredient in Norvasc

Drawio
bordertrue
diagramNameSubstance active ingredient role in included in product - Amlodipine mesylate monohydrate plays the active ingredient in Amlodipine EMC
simpleViewerfalse
width
linksauto
tbstyletop
lboxtrue
diagramWidth1041
revision2

The important thing is that we can now attach all information that further specifies the role of Amlodipine mesylate monohydrate in the context of Amlodipine EMC to the middle role node in the graph. E.g., strength.

Roles and Constituents (Product Compositions)

More complex case, where multiple roles need to be grouped and or distinguished in their representation, can be covered with the following constituency pattern.

Drawio
bordertrue
diagramNameConstituencies
simpleViewerfalse
width
linksauto
tbstyletop
lboxtrue
diagramWidth601
revision5



Role Hierarchy in IDMP-O

The role (https://www.omg.org/spec/Commons/PartiesAndSituations/Role) is modeled as a class and can be specialized with sub-classes some of which are shown in diagram 2.

...

Diagram 2: The role class and its specialized sub-classes.


Context Definition

The context is a "situation" or frame of reference in which something applies, exists, happens, or is used and that helps to illustrate or explain it. As with roles, contexts can be further specified with sub-classes as shown in Diagram 3.

...

Diagram 3: Context and its sub-classes.

Examples

Modeling the active moiety role for Amlodipine bezylate in the regulatory context

Amlodipine bezylate is used here as a simple example to demonstrate the modeling pattern for contextualized roles, where Amlodipine plays the active moiety role for the drug Amlodipine bezylate in a regulatory context.

...

Diagram 4: Modeling Amlodipine as the active moiety for Amlodipine bezylate in a regulatory context


Modeling the different active moiety roles for Aripiprazole lauroxil in different contexts

The contextualized role pattern is used here to model interpretations of the active moiety role for Aripiprazole in different situations. Aristada is a drug developed by Alkermes and is composed of Aripiprazole lauroxil. Aripiprazole lauroxil is first metabolized to N-hydroxymethyl aripiprazole, which is then further metabolized to Aripiprazole which exerts pharmaceutical effects in the body. From a regulatory perspective, Aripiprazole is thus the active moiety. However, based on the interpretation of a patent by the US court, based on the fillings by the owner of the intellectual property (IP) on Aripiprazole lauroxil, the active component is stated as the N-hydroxymethylated product instead. Diagrams 5 and 6 below demonstrate how in different contexts, the active moiety for Aripiprazole lauroxil can be either N-hydroxymethyl aripripazole or Aripiprazole itself.

...

In the third example, the USP salt policy context is considered when naming the active moiety for Aripiprazole lauroxil. The USP (United States Pharmacopeia) Salt Policy outlines a naming and labeling approach for drug products containing an active ingredient that is a salt, and applies to drug product monograph titles published after the 1st of May 2013. According to the USP salt policy, Aripiprazole lauroxil is designated as the active moiety for Aripiprazole lauroxil (Diagram 7).

Moiety Role - N-hydroxymethyl aripiprazole - Patent Exclusivity

Drawio
bordertrue
diagramNameMoiety Role - Aripiprazole - FDA Patent Exclusivity - simplified
simpleViewerfalse
linksauto
tbstyletop
diagramDisplayNameN-hydroxymethyl aripiprazole as the active moiety for Aripiprazole lauroxil in a FDA patent exclusivity regulatory context
lboxtrue
diagramWidth883
revision3

Diagram 5: Modeling N-hydroxymethyl aripiprazole as the active moiety for Aripiprazole lauroxil in a FDA patent exclusivity context

Moiety Role - Aripiprazole - Regulatory Context GSRS

Drawio
bordertrue
diagramNameMoiety Role - Aripiprazole - FDA GSRS context
simpleViewerfalse
linksauto
tbstyletop
diagramDisplayNameAripiprazole as the active moiety for Aripiprazole lauroxil in a FDA GSRS context
lboxtrue
diagramWidth782
revision2

Diagram 6: Modeling Aripiprazole as the active moiety for Aripiprazole lauroxil in a regulatory FDA GSRS context

Moiety Role - Aripiprazole - USP Salt Policy context

Drawio
bordertrue
diagramNameCopy of Moiety Role - Aripiprazole - FDA GSRS context
simpleViewerfalse
linksauto
tbstyletop
diagramDisplayNameAripiprazole lauroxil as the active moiety for Aripiprazole lauroxil in a USP salt policy context
lboxtrue
diagramWidth791
revision2

...

View file
nameExample Aripiprazole.docx
height250

USP documentation


View file
name1121Nomenclature.pdf
height250
View file
nameNaming-of-Drug-Products-Containing-Salt-Drug-Substances.pdf
height250

...